Vestal Point Capital, LP Portfolio Holdings
Vestal Point Capital, LP
- $1.21 Trillion
- Q1 2024
Vestal Point Capital, LP has filed its 13F form on May 13, 2024 for Q1 2024 where it was disclosed a total value porftolio of $1.21 Trillion distributed in 58 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Cytokinetics Inc with a value of $151B, Jazz Pharmaceuticals PLC with a value of $132B, Neurocrine Biosciences Inc with a value of $97.9B, Ascendis Pharma A/S with a value of $79.4B, and Globus Medical Inc with a value of $53.6B.
Examining the 13F form we can see an increase of $265B in the current position value, from $944B to 1.21T.
Vestal Point Capital, LP is based out at New York, NY
Below you can find more details about Vestal Point Capital, LP portfolio as well as his latest detailed transactions.